# Altimmune, Inc. (ALT)

> Source: Nexqual · https://nexqual.com/ALT · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, Altimmune, Inc. (ALT), nexqual.com/ALT" · informational, not investment advice.

**Price:** USD 2.36 (+2.16% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 2.31 · day 2.29–2.38 · 52w 2.29–6.44 · market cap $459M · NGM

## Key facts
- 1 of 80 tracked superinvestors hold ALT (13F, Q2 2026): 1 new, 0 added, 0 reduced, 0 unchanged.
- Analysts: Buy (mean 1.90 on a 1–5 scale) (10 analysts), mean target USD 17.11 (range 11–28).
- Total return with dividends: 1Y -39.3% vs S&P 500 +18.1%; 5Y -80.3% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD -0.14, revenue estimate $0K.

## Superinvestors (SEC 13F-HR, Q2 2026)
1 of 80 tracked investors hold ALT. Change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Viking Global | Viking Global Investors | 0.06% | $20.4M | New position |

## Analysts
Consensus Buy (mean 1.90 on a 1–5 scale), 10 analysts; mean target USD 17.11 (low 11, high 28).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-23 | Evercore ISI Group | Target lowered | Outperform | $18 → $17 |
| 2026-06-22 | Leerink Partners | Initiated | Outperform | $10 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -39.3% | -80.3% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -39.4% | -27.7% |
| Volatility (annualized) | 70.5% | 97.8% |
| Max drawdown | -62.6% (Jan 2026→Oct 2026) | -90.3% (Aug 2022→Oct 2023) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/ALT · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt